Company · CIK 1810031

# Freeline Therapeutics Holdings plc

| CIK | [1810031](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001810031) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | X0 |
| Business address | United Kingdom |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-03-31 |

## Offerings

 2 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-259444 | Shelf Effective | 2021-09-10 | 2024-02-23 | 7 |
| 333-239938 | IPO Final prospectus | 2020-07-17 | 2020-08-10 | 4 |

## Filings

 13

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2024-02-23 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1810031/999999999524000522/9999999995-24-000522-index.htm) Declared effective | 333-259444 | 9999999995-24-000522 |
| 2022-04-07 | [424B5](https://www.sec.gov/Archives/edgar/data/1810031/000119312522099022/0001193125-22-099022-index.htm) Shelf takedown | 333-259444 | 0001193125-22-099022 |
| 2022-03-22 | [424B5](https://www.sec.gov/Archives/edgar/data/1810031/000119312522081630/0001193125-22-081630-index.htm) Shelf takedown | 333-259444 | 0001193125-22-081630 |
| 2022-03-11 | [424B5](https://www.sec.gov/Archives/edgar/data/1810031/000119312522072687/0001193125-22-072687-index.htm) Shelf takedown | 333-259444 | 0001193125-22-072687 |
| 2021-11-17 | [424B5](https://www.sec.gov/Archives/edgar/data/1810031/000119312521332449/0001193125-21-332449-index.htm) Shelf takedown | 333-259444 | 0001193125-21-332449 |
| 2021-09-22 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1810031/999999999521003629/9999999995-21-003629-index.htm) Declared effective | 333-259444 | 9999999995-21-003629 |
| 2021-09-10 | [F-3](https://www.sec.gov/Archives/edgar/data/1810031/000119312521269951/0001193125-21-269951-index.htm) Shelf registered | 333-259444 | 0001193125-21-269951 |
| 2020-08-10 | [424B4](https://www.sec.gov/Archives/edgar/data/1810031/000119312520215070/0001193125-20-215070-index.htm) Final prospectus | 333-239938 | 0001193125-20-215070 |
| 2020-08-06 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1810031/999999999520002060/9999999995-20-002060-index.htm) Declared effective | 333-240125 | 9999999995-20-002060 |
| 2020-08-06 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1810031/999999999520002056/9999999995-20-002056-index.htm) Declared effective | 333-239938 | 9999999995-20-002056 |
| 2020-08-03 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1810031/000119312520207194/0001193125-20-207194-index.htm) Amendment | 333-239938 | 0001193125-20-207194 |
| 2020-07-17 | [F-1](https://www.sec.gov/Archives/edgar/data/1810031/000119312520194813/0001193125-20-194813-index.htm) Registration filed | 333-239938 | 0001193125-20-194813 |
| 2020-05-07 | [DRS](https://www.sec.gov/Archives/edgar/data/1810031/000095012320004065/0000950123-20-004065-index.htm) Draft made public | 377-03158 | 0000950123-20-004065 |

[All filings of this company](https://equitycapital.markets/filings?cik=1810031) · [CSV](https://equitycapital.markets/filings.csv?cik=1810031)

---
Source page: https://equitycapital.markets/company/1810031 · Data: U.S. SEC EDGAR · CC BY 4.0